文献速递心律失常

基于生物标志物预测房颤患者随访期窦性心律:EAST-AFNET 4生物分子研究

Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study.
PubMed 文献 · Eur Heart J · 2024-01-01

该研究在EAST-AFNET 4试验的1586例房颤患者中量化了14种反映房颤相关心血管疾病过程的基线生物标志物,构建混合逻辑回归模型分析其与12个月窦性心律的关系。结果显示ANGPT2、BMP10和NT-proBNP浓度较低独立预测12个月窦性心律达标,24个月结果一致,且NT-proBNP的预测能力在早期节律控制组中减弱。外部验证支持上述三种生物标志物的预测价值。

要点

  • 基线ANGPT2、BMP10、NT-proBNP较低者12个月窦性心律达标可能性更高。
  • NT-proBNP的预测能力在随机接受早期节律控制者中减弱。
  • 24个月随访及外部数据集验证了上述生物标志物的预测价值。

核心结论

  • 低浓度ANGPT2、BMP10和NT-proBNP可识别随访期间可能达到窦性心律的房颤患者。
  • NT-proBNP的预测能力在接受节律控制的患者中减弱。

研究设计与样本

  • EAST-AFNET 4生物分子研究,纳入1586例房颤患者(71岁,45%女性),基线定量14种生物标志物,构建包含临床特征的混合逻辑回归模型,主要结局为12个月窦性心律,并在24个月及外部数据集验证。

主要发现

  • 24个月心律分析证实上述结果。

临床怎么用

  • 可检测基线ANGPT2、BMP10和NT-proBNP以辅助识别随访期可能恢复窦性心律的房颤患者。
  • 对NT-proBNP较高的患者,早期节律控制可能减弱其不良预测影响,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: In patients with atrial fibrillation (AF), recurrent AF and sinus rhythm during follow-up are determined by interactions between cardiovascular disease processes and rhythm control therapy. Predictors of attaining sinus rhythm at follow-up are not well known. METHODS: To quantify the interaction between cardiovascular disease processes and rhythm outcomes, 14 biomarkers reflecting AF-related cardiovascular disease processes in 1586 patients in the EAST-AFNET 4 biomolecule study (71 years old, 45% women) were quantified at baseline. Mixed logistic regression models including clinical features were constructed for each biomarker. Biomarkers were interrogated for interaction with early rhythm control. Outcome was sinus rhythm at 12 months. Results were validated at 24 months and in external datasets. RESULTS: Higher baseline concentrations of three biomarkers were independently associated with a lower chance of sinus rhythm at 12 months: angiopoietin 2 (ANGPT2) (odds ratio [OR] .76 [95% confidence interval .65-.89], P < .001), bone morphogenetic protein 10 (BMP10) (OR .83 [.71-.97], P = .017), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) (OR .73 [.60-.88], P < .001). Analysis of rhythm at 24 months confirmed the results. Early rhythm control interacted with the predictive potential of NT-proBNP (Pinteraction = .033). The predictive effect of NT-proBNP was reduced in patients randomized to early rhythm control (usual care: OR .64 [.51-.80], P < .001; early rhythm control: OR .90 [.69-1.18], P = .453). External validation confirmed that low concentrations of ANGPT2, BMP10, and NT-proBNP predict sinus rhythm during follow-up. CONCLUSIONS: Low concentrations of ANGPT2, BMP10, and NT-proBNP identify patients with AF who are likely to attain sinus rhythm during follow-up. The predictive ability of NT-proBNP is attenuated in patients receiving rhythm control.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Fabritz L, Al-Taie C, Borof K, et al. Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study. Eur Heart J. 2024. PMID: 39215973. doi:10.1093/eurheartj/ehae611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。